# Acadia Pharmaceuticals Inc: Form 8-K, filed Oct 23, 2026

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: 8-K
- Filed: 2026-10-23
- Accepted by EDGAR: Oct 23, 2026, 16:51 ET
- Period: 2026-10-23
- Accession: 0001193125-26-430596
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000119312526430596/acad-20261023.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000119312526430596/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000119312526430596/acad-20261023.htm

Filed Oct 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-430596. Last ingested by Listed: Nov 4, 2026, 17:11 ET. No prices; not investment advice.